<?xml version="1.0" encoding="UTF-8"?>
<ref id="R40">
 <label>40.</label>
 <mixed-citation publication-type="book">
  <comment>Food and Drug Administration. Revised Information for Investigational COVID-19 Convalescent Plasma. 2020; 
   <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/vaccinesblood-biologics/investigational-new-drug-ind-or-device-exemptionide-process-cber/revised-information-investigational-covid-19-convalescent-plasma" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fda.gov/vaccinesblood-biologics/investigational-new-drug-ind-or-device-exemptionide-process-cber/revised-information-investigational-covid-19-convalescent-plasma</ext-link>. Accessed April 08, 2020.
  </comment>
 </mixed-citation>
</ref>
